Skip to main content
Erschienen in: Journal of Cancer Education 4/2020

03.05.2019

Evaluation of Quality of Life and Health Care Needs in Cancer Patients Receiving Chemotherapy

verfasst von: Gamze Temiz, Zehra Durna

Erschienen in: Journal of Cancer Education | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Symptoms are decisive in the quality of life of patients. Progression of the underlying disease leads to many physical and psychological symptoms in patients. Increases in these symptoms often prevent patients from complying with treatment. Therefore, the symptoms must be recognized, evaluated, and controlled for the treatment to be effective. This study determined the unmet needs of patients undergoing chemotherapy treatment and the effects of these needs on the patients’ quality of life. Four hundred fifty patients were studied. Data were collected using the Patient Information Form, the Nightingale Symptom Assessment Scale (N-HAQ), the Supportive Care Requirements Questionnaire (DBGÖ), and the FACT-G (v4) Quality of Life Scale. The areas in which patients needed the most support were pain, weakness/fatigue, bad feelings, sadness, mood swings, difficulty in doing home-related tasks, fear of the cancer spreading, inability to control the situation, worries about the future, fear of death, worries about upsetting relatives, and being in need of information regarding their sexual lives. The results showed that for patients who had higher support requirements, higher incidences of symptoms led to a reduced quality of life. Consequently, frequently evaluating these symptoms to meet the needs identified, frequently measuring the quality and efficiency of care and advising these patients on their needs is recommended.
Literatur
1.
Zurück zum Zitat Durna Z (2013) Internal medicine nursing, İstanbul. Academy Press and Publication Durna Z (2013) Internal medicine nursing, İstanbul. Academy Press and Publication
3.
Zurück zum Zitat Can G (2013b) Neoplastic Diseases and Care. In: Durna Z (ed) Internal Medicine Nursing. Academy Press and Publication, İstanbul, pp 255–271 Can G (2013b) Neoplastic Diseases and Care. In: Durna Z (ed) Internal Medicine Nursing. Academy Press and Publication, İstanbul, pp 255–271
4.
Zurück zum Zitat Can G (2014a) Oncology nursing. Nobel Medical Bookstore, İstanbul Can G (2014a) Oncology nursing. Nobel Medical Bookstore, İstanbul
5.
Zurück zum Zitat Can G (2014b) From evidence to practice in oncology nursing. Oncology nursing. Nobel Medical Bookstore, İstanbul Can G (2014b) From evidence to practice in oncology nursing. Oncology nursing. Nobel Medical Bookstore, İstanbul
6.
Zurück zum Zitat Koşar A, Öztürk M (2004). Internal sciences. Nobel Medical Bookstore, İstanbul Koşar A, Öztürk M (2004). Internal sciences. Nobel Medical Bookstore, İstanbul
7.
Zurück zum Zitat Ergüney S (2013) AJCC atlas of cancer staging. Nobel Medical Bookstore, İstanbul Ergüney S (2013) AJCC atlas of cancer staging. Nobel Medical Bookstore, İstanbul
11.
Zurück zum Zitat Çeler HG, Özyurt BC, Elbi H, Özcan F (2017) Evaluation of the quality of life and the burden of care in the relatives of breast cancer patients. Ank Med J 18(2):164–174 Çeler HG, Özyurt BC, Elbi H, Özcan F (2017) Evaluation of the quality of life and the burden of care in the relatives of breast cancer patients. Ank Med J 18(2):164–174
16.
Zurück zum Zitat Kahveci K, Gökçınar D (2014) Palliative care. Nobel Medical Bookstore, İstanbul Kahveci K, Gökçınar D (2014) Palliative care. Nobel Medical Bookstore, İstanbul
17.
Zurück zum Zitat Diplock BD, McGarragle KM, Mueller WA, Haddad S, Ehrlich R, Yoon DHA, Myers J, Mitchell AJ, Ellis JWM (2018) The impact of automated screening with Edmonton symptom assessment system (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients. Support Care Cancer 27:1–10. https://doi.org/10.1007/s00520-018-4304-0 CrossRef Diplock BD, McGarragle KM, Mueller WA, Haddad S, Ehrlich R, Yoon DHA, Myers J, Mitchell AJ, Ellis JWM (2018) The impact of automated screening with Edmonton symptom assessment system (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients. Support Care Cancer 27:1–10. https://​doi.​org/​10.​1007/​s00520-018-4304-0 CrossRef
25.
Zurück zum Zitat Bayram Z (2012). Assessment of symptoms and care requirements in patients receiving breast cancer chemotherapy. Haliç University Institute of Health Sciences (Advisor: Prof. Dr. Zehra Durna) Bayram Z (2012). Assessment of symptoms and care requirements in patients receiving breast cancer chemotherapy. Haliç University Institute of Health Sciences (Advisor: Prof. Dr. Zehra Durna)
26.
Zurück zum Zitat So WKW, Choi KC, Chen JMT, Chan CWH, Chair SY, Fung OWM, Wan RWM, Mak SSS, Ling WM, Ng WT, Bernice WLY (2014) Quality of life in head and neck cancer survivors at 1 year after treatment: the mediating role of unmet supportive care needs. Eur J Oncol Nurs 22(11):2917–2926. https://doi.org/10.1007/s00520-014-2278-0 CrossRef So WKW, Choi KC, Chen JMT, Chan CWH, Chair SY, Fung OWM, Wan RWM, Mak SSS, Ling WM, Ng WT, Bernice WLY (2014) Quality of life in head and neck cancer survivors at 1 year after treatment: the mediating role of unmet supportive care needs. Eur J Oncol Nurs 22(11):2917–2926. https://​doi.​org/​10.​1007/​s00520-014-2278-0 CrossRef
28.
Zurück zum Zitat Çetiner M, Kalaca S, Birtaş E (2004) Evaluation of quality of life in patients with hematopoietic coke cell transplantation. Turk J Hematol 21:6–7 ISSN: 1300-7777 E-ISSN: 1308-5263 Çetiner M, Kalaca S, Birtaş E (2004) Evaluation of quality of life in patients with hematopoietic coke cell transplantation. Turk J Hematol 21:6–7 ISSN: 1300-7777 E-ISSN: 1308-5263
29.
Zurück zum Zitat Gültekin Z, Pınar G, Pınar T, Kızıltan G, Doğan N, Algıer L, Bulut I, Özyılkan Ö (2008) Health-related quality of life and health care services expectations of the patients with lung Cancer. Int J Hematol Oncol 2:18 Gültekin Z, Pınar G, Pınar T, Kızıltan G, Doğan N, Algıer L, Bulut I, Özyılkan Ö (2008) Health-related quality of life and health care services expectations of the patients with lung Cancer. Int J Hematol Oncol 2:18
30.
Zurück zum Zitat Arslan S, Akın B, Koçoğlu D (2008) The relationship between the socio-demographic characteristics and perceived social support of the symptoms related to disease and treatment in patients receiving chemotherapy. J Nurs Res 1:1. ISSN:1307- 9557 (Basılı), ISSN: 1307- 9549 (Online) Arslan S, Akın B, Koçoğlu D (2008) The relationship between the socio-demographic characteristics and perceived social support of the symptoms related to disease and treatment in patients receiving chemotherapy. J Nurs Res 1:1. ISSN:1307- 9557 (Basılı), ISSN: 1307- 9549 (Online)
Metadaten
Titel
Evaluation of Quality of Life and Health Care Needs in Cancer Patients Receiving Chemotherapy
verfasst von
Gamze Temiz
Zehra Durna
Publikationsdatum
03.05.2019
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2020
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01533-2

Weitere Artikel der Ausgabe 4/2020

Journal of Cancer Education 4/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.